WHO validates China's Convidecia as 11th vaccine for COVID-19

Vaccines |  News | 0 Comment | 20 May, 2022

The World Health Organization (WHO) has issued an emergency use listing (EUL) for Convidecia, a vaccine manufactured by ...Read more

Korea expands collaboration in vaccine development, delivery & training

Vaccines |  News | 0 Comment | 17 May, 2022

The International Vaccine Institute (IVI) and the Disease Control and Prevention Agency (KDCA), Republic of Korea (ROK),...Read more

SK bioscience acquires approval for typhoid conjugate vaccine

Vaccines |  News | 0 Comment | 17 May, 2022

South Korea-based SK Bioscience has secured another approval for in-house vaccine. SK Bioscience obtained an export lic...Read more

India-Australia collaboration to develop ‘variant-proof’ COVID-19 vaccine

Vaccines |  News | 0 Comment | 10 May, 2022

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is providing funding of up to $19.3 million to suppo...Read more

China approves phase 2 trial of recombinant protein COVID-19 vaccine, ReCOV

Vaccines |  News | 0 Comment | 05 May, 2022

Jiangsu Recbio Technology Co., Ltd. has recently received the clinical trial approval for its recombinant protein COVID-...Read more

Zhifei Lvzhu Biopharmaceutical to commercialise whooping cough vaccine in China

Vaccines |  News | 0 Comment | 03 May, 2022

Intravacc B.V., located at Utrecht Science Park Bilthoven in the Netherlands, has announced the signing o...Read more

SK bioscience reaches final stage of developing Korea´s first COVID-19 vaccine

Vaccines |  News | 0 Comment | 02 May, 2022

South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...Read more

Korean firm GC Biopharma explores use of lipid nanoparticle delivery system in mRNA vaccines

Vaccines |  News | 0 Comment | 28 Apr, 2022

GC Biopharma, based in South Korea, and Canadian firm Acuitas Therapeutics, a company focused on developing lipid nanopa...Read more

Sanofi gears to leverage Evolutive Vaccine Facility (EVF) in Asia by 2025

Vaccines |  News | 0 Comment | 20 Apr, 2022

On 20 April 2022, Sanofi launched Evolutive Vaccine Facility (EVF) in Singapore. A first-of-its-kind, the...Read more

Japan approves Novavax's COVID-19 vaccine for primary and booster immunisation

Vaccines |  News | 0 Comment | 19 Apr, 2022

Takeda Pharma has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (M...Read more

Korea promotes vaccine development & delivery, bio-manufacturing training for LMICs

Vaccines |  News | 0 Comment | 08 Apr, 2022

The International Vaccine Institute (IVI) and the Ministry of Health and Welfare (MOHW), Republic of Korea, have agreed ...Read more

Thailand gives Emergency Use Authorisation for Novavax' COVID-19 vaccine

Vaccines |  News | 1 Comment | 08 Apr, 2022

US-based Novavax, Inc. and Serum Institute of India have announced that the Thailand Food and Drug Administration (Thai ...Read more

CEPI partners with Japan’s NEC Group for AI-designed betacoronavirus vaccine

Vaccines |  News | 0 Comment | 08 Apr, 2022

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation in Japan have announced the ...Read more

Chinese firms strengthen focus on development and commercialisation of mRNA vaccines

Vaccines |  News | 0 Comment | 07 Apr, 2022

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...Read more

China approves clinical trial for CanSinoBIO's COVID-19 mRNA vaccine

Vaccines |  News | 0 Comment | 05 Apr, 2022

CanSino Biologics has announced that the National Medical Products Administration of China (NMPA) granted approval for t...Read more

New trial in Australia could help increase supply of Japanese encephalitis vaccine

Vaccines |  News | 0 Comment | 01 Apr, 2022

A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable a...Read more

Singapore's Prestige Biopharma inks MoU for co-development of COVID-19/Influenza vaccine

Vaccines |  News | 0 Comment | 30 Mar, 2022

Singapore-based Prestige Biopharma and Vaxine have entered into a memorandum of understanding (MoU) to collabo...Read more

Australia commences recruitment for Ph 1 trial of two indigenous COVID-19 vaccines

Vaccines |  News | 0 Comment | 28 Mar, 2022

Melbourne researchers are calling on healthy people aged 18-70 living in Victoria to roll up their sleeves for a Phase 1...Read more